Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 20, 2025 • 12:41 PM ET

Date/Time Source News Release
06/03/2025 07:00 AM EDT Newsfile Kiora Pharmaceuticals and Senju Pharmaceutical Partner on KIO-301 for the Treatment of Retinal Diseases in Asia
05/09/2025 07:00 AM EDT Newsfile Kiora Pharmaceuticals Reports First Quarter Results; Initiating Two Phase 2 Trials for Treatment of Retinal Diseases; Cash and Short-term Investments Expected to Fund Operations into Late 2027
05/05/2025 07:00 AM EDT Newsfile Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy
04/04/2025 07:00 AM EDT Newsfile Kiora Pharmaceuticals to Present at The 24th Annual Needham Virtual Healthcare Conference
03/25/2025 07:00 AM EDT Newsfile Kiora Pharmaceuticals Reports 2024 Results; Retinal Disease Drug Development Pipeline Continues to Advance; Cash and Short-Term Investments Expected to Fund Operations into 2027
03/12/2025 07:00 AM EDT Newsfile Kiora Pharmaceuticals to Present Preclinical Data on KIO-104 for the Treatment of Proliferative Vitreoretinopathy at the ARVO 2025 Annual Meeting
02/13/2025 07:00 AM EST Newsfile Kiora Pharmaceuticals Secures U.S. Composition-of-Matter Patent Expanding Protection of Its Anti-Inflammatory Compound KIO-104
02/11/2025 06:45 AM EST Newsfile Kiora Receives Approval to Initiate KLARITY, a Phase 2 Clinical Trial of KIO-104 for the Treatment of Retinal Macular Edema
11/08/2024 07:00 AM EST Newsfile Kiora Pharmaceuticals Reports Third Quarter Results; Retinal Disease Pipeline Advancing Two Phase 2 Studies
10/29/2024 06:45 AM EDT Newsfile Kiora Pharmaceuticals Receives Investigational New Drug Approval to Initiate ABACUS-2, a Phase 2 Clinical Trial of KIO-301 for the Treatment of Retinitis Pigmentosa
Page

Additional News

As of June 20, 2025 • 12:41 PM ET

Date/Time Source News Release
06/03/2025 09:25 AM EDT 24/7 Market News Top Must-Watch Stocks: Disruptive Deals, Strategic Milestones, and Emerging Market Leaders to Watch
05/10/2025 05:30 AM EDT US Earnings Reports Expected earnings - Kiora Pharmaceuticals Inc.
05/09/2025 07:28 AM EDT SeekingAlpha Kiora Pharmaceuticals GAAP EPS of -$0.52
05/08/2025 06:48 PM EDT KlickAnalytics KPRX - Historical Price Movements Surrounding Earnings
05/08/2025 06:43 PM EDT KlickAnalytics KPRX - Historical Earnings Price Analysis
03/25/2025 07:15 AM EDT SeekingAlpha Kiora Pharmaceuticals GAAP EPS of $0.87 beats by $0.01, revenue of $16.02M misses by $0.75M
03/24/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, March 24th, 2025
03/24/2025 05:31 AM EDT US Earnings Reports Expected earnings - Kiora Pharmaceuticals Inc.
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Kiora Pharmaceuticals Inc.
11/08/2024 07:26 AM EST SeekingAlpha Kiora Pharmaceuticals GAAP EPS of -$0.81 misses by $0.05
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.